Fingerprint
Dive into the research topics of 'Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: Results from a phase III randomized trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically